NCT07685106

Brief Summary

This is a prospective, observational study conducted in the emergency department. Adult patients presenting with dyspnea will be enrolled, and study data will be collected from routine clinical assessments, including medical history, physical examination, laboratory tests, and echocardiography results, as well as non-invasive cardiovascular measurements obtained using the CardioStory device.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
850

participants targeted

Target at P75+ for all trials

Timeline
4mo left

Started Sep 2025

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Sep 2025Dec 2026

Study Start

First participant enrolled

September 1, 2025

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 26, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 6, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 6, 2026

Status Verified

July 1, 2026

Enrollment Period

1.2 years

First QC Date

June 26, 2026

Last Update Submit

July 2, 2026

Conditions

Keywords

dyspneaHeart failurenon-cardiac causes of dyspneacardiostorycardiac assessment devicecardiac causes of dyspnea

Outcome Measures

Primary Outcomes (1)

  • Diagnostic performance assessment of the CardioStory device.

    To assess the diagnostic performance of the CardioStory device in differentiating patients with heart failure from those with non-cardiac causes of dyspnea (including respiratory, metabolic etiologies) in patients presenting to the emergency department, using standard clinical assessments as the reference standard.

    Day 1

Secondary Outcomes (4)

  • To evaluate the sensitivity and specificity of the CardioStory device for the diagnosis of heart failure.

    Day 1

  • To compare the diagnostic results obtained with CardioStory device with reference diagnostic tools

    Day 1

  • To evaluate the time required to obtain measurements using the CardioStory device compared with standard clinical assessments.

    Day 1

  • To assess the adverse event occurrences of the CardioStory device in the emergency setting.

    Day 1

Study Arms (1)

Patients suffering from Dyspnea

Adult patients presenting to the emergency department with acute dyspnea.

Device: Non invasive cardiac assessment with the CardioStory device

Interventions

The CardioStory device, is a non-invasive medical technology designed to rapidly (approximately 2 minutes) assess cardiac filling pressure in patients with suspected or established heart failure. It uses proprietary fiber-optic sensors combined with advanced signal processing and analytical algorithms to detect and analyze physiological signals related to cardiac mechanical function. These signals are processed to generate a quantitative estimate of cardiac filling pressure without the need for catheterization, contrast agents, or injectable substances. The measurement is performed non-invasively and is designed to be simple, rapid, and reproducible.

Patients suffering from Dyspnea

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients presenting to the emergency department with acute or subacute dyspnea without an established diagnosis. This population represents patients requiring urgent evaluation to differentiate between cardiac and non-cardiac causes of dyspnea.

You may qualify if:

  • Age ≥ 18 years
  • Recent onset dyspnea (less than 7 days)
  • Informed consent obtained

You may not qualify if:

  • Age inferior to 18 years,
  • Dyspnea clearly of traumatic or allergic origin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Fattouma bourguiba university hospital

Monastir, Monastir Governorate, 5000, Tunisia

RECRUITING

Sahloul university hospital

Sousse, 4054, Tunisia

RECRUITING

MeSH Terms

Conditions

Heart FailureDyspnea

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2026

First Posted

July 6, 2026

Study Start

September 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 6, 2026

Record last verified: 2026-07

Locations